Sovleplenib

HMPL-523 · Hutchison Medipharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sovleplenib, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia [Phase 2, Phase 3]